Llwytho...
The need for additional genetic markers for MDS stratification: what does the future hold for prognostication?
Myelodysplastic syndromes (MDS) constitute a heterogeneous group of clonal hematopoietic disorders. Metaphase cytogenetics (MC) has been the gold standard for genetic testing in MDS, but it can detect clonal cytogenetic abnormalities in only 50% of cases. New karyotyping tests include fluorescence i...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Expert Rev Hematol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2013
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4535709/ https://ncbi.nlm.nih.gov/pubmed/23373781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ehm.12.67 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|